Kavita Patel is a Nonresident Fellow at the Brookings Institution. Previously, she was the managing director of clinical transformation at the Center for Health Policy.

Dr. Patel is a practicing primary care internist at Johns Hopkins Medicine. She also served in the Obama Administration as director of policy for the Office of Intergovernmental Affairs and Public Engagement in the White House. As a senior aide to Valerie Jarrett, President Obama’s senior advisor, Dr. Patel played a critical role in policy development and evaluation of policy initiatives connected to health reform, financial regulatory reform, and economic recovery issues.

Dr. Patel also has a deep understanding of Capitol Hill from her time spent on the late Senator Edward Kennedy’s staff. As deputy staff director on health, she served as a policy analyst and trusted aide to the Senator and was part of the senior staff of the Health, Education, Labor and Pensions (HELP) Committee under Sen. Kennedy’s leadership. She also has an extensive research and clinical background, having worked as a researcher at the RAND Corporation and as a practicing physician in both California and Oregon. She is a previous Robert Wood Johnson Clinical Scholar, and while at Brookings, she will return to providing clinical care as an internal medicine practitioner. She earned her medical degree from the University of Texas Health Science Center and her masters in public health from the University of California Los Angeles.


Recent Posts by Kavita Patel

From Hotspot To Health Hub: How Communication And Data Can Help Solve The Growing Health Divide

Neighborhoods within cities have the power to be health hubs and create a long-term, positive health impact, say these two authors. A project in the District of Columbia, partially supported by the Aetna Foundation, addresses high-risk populations.

How Should The Trump Administration Handle Medicare’s New Bundled Payment Programs?

HHS has several options for addressing Secretary Price’s prior objections to the hospital-at-risk structure of the CJR and EPM models that could maintain the integrity of these payment reform initiatives. However, the Department does not have a good alternative to the mandatory structure used...

April 10, 2017Costs and Spending, Medicare, Quality

A Fair Plan For Fairer Drug Prices

Policies giving federal and state governments authority to set drug prices or limit price increases could have the unintended consequence of reducing the incentive to develop more effective drugs. However, certain regulatory reforms can address these concerns and encourage more robust...

CMMI’s New Comprehensive Primary Care Plus: Its Promise And Missed Opportunities

The Center for Medicare and Medicaid Innovation recently announced an initiative called Comprehensive Primary Care Plus (CPC+). The program has some very promising components, but also misses some compelling opportunities to further advance payment for primary care services.

A Controversial New Demonstration In Medicare: Potential Implications For Physician-Administered Drugs

Some of the most expensive drugs are covered under Medicare’s medical benefit, Part B, because they are administered by a physician. The high growth rate of Part B drug spending is a concern, especially as expensive breakthrough cancer drugs enter the market.

Loan Fund Helps Safety-Net Providers Grow And Innovate

Safety-net providers often have trouble accessing capital, making it hard for them to keep pace with the demands of the changing health care industry. A new $30 million loan fund may help.

Getting Enrolled Isn’t Enough: The Importance Of Teaching Consumers How To Use Health Insurance

As we enter the third Marketplace open enrollment period, we are faced with evidence that consumers do not understand health insurance. We believe knowing how to use health insurance effectively is key to getting the right care at the right time in the right place.

Closing The Rural Health Connectivity Gap: How Broadband Funding Can Better Improve Care

Broadband access is not usually highlighted in policy prescriptions for improving outcomes and lowering costs of health care. But it is a prerequisite for a range of technologies that can provide more cost-effective and higher-quality care, such as video consultation, remote patient monitoring,...

How Open Data Can Reveal—And Correct—The Faults In Our Health System

In April 2014, the Centers for Medicare and Medicaid (CMS) released millions of lines of Medicare Part B physician payment data, that led many researchers, analysts, journalists, and the general public to use the data to answer a number of pressing health care questions. And while the dataset...

How Hepatitis C Is Shining A Light On Critical Gaps In Payment Reform

Since December 2013, regulatory approval of new treatments for hepatitis C have brought long simmering debates on drug pricing and value to full boil. The drugs---Gilead’s Sovaldi and successor combination treatment Harvoni, AbbVie’s Viekira Pak---represent significant steps forward for...